Wednesdays, noon-1 p.m.
This 12 session ECHO series will help build or improve care systems to effectively treat addiction in a hospital setting. Topics may include:
Hospital clinicians (prescribing MD, DO, NP, PAs), nurses, social workers, pharmacists, discharge planners, behavioral health specialists, administrators, and quality improvement specialists are encouraged to register. Ideally staff will participate as part of a hospital-based team that includes a clinician and one or more other staff member. Participants will be selected based on their interest and geographic distribution throughout Oregon.
Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians
Credit: OHSU School of Medicine designates this live activity for a maximum 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is registered for MOC through the American Board of Internal Medicine (ABIM)
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Substance Use Disorder in Hospital Care has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: Family Medicine, Psychiatry and Neurology, and Preventive Medicine
FACULTY DISCLOSURE INFORMATION
In accordance with the requirements of the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education, each instructor and member of the planning committee has been asked to disclose any relevant financial relationships with commercial interests (defined as: any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). The information disclosed for this activity is listed below.
PROGRAM PLANNING COMMITTEE
Honora Englander, M.D., F.A.C.P.: Nothing to Disclose
Jessica Gregg, M.D., Ph.D.: Nothing to Disclose
|Basilia Basin, Ph.D., R.N.: Nothing to Disclose||Jessica Gregg, M.D., Ph.D.: Nothing to Disclose|
|Honora Englander, M.D., F.A.C.P.: Nothing to Disclose||Ximena Levander, M.D.: Nothing to Disclose|
|Amelia Goff, NP: Nothing to Disclose||Susannah Lujan-Bear, MSN, RN: Nothing to Disclose|
|Traci Lundy, IPS, PSS, PWS: Nothing to Disclose||Kate Marshall, MD: Nothing to Disclose|
|Stacey Mahoney, L.C.S.W., C.A.D.C. II: Nothing to Disclose||Emily Skogrand, PharmD: Nothing to Disclose|
|Juliana Wallace, LCSW: Nothing to Disclose||Lisa Whitmore, RN, BC-FNP: Nothing to Disclose|
|0 - General Resources||2/1/2021|
|1 - ECHO Introduction and Basics||4/7/2021|
|2 - Buprenorphine in Hospital Care||4/14/2021|
|3 - Methadone in Hospital Care||4/21/2021|
|4 - Trauma Informed Care in a Hospital Setting||4/28/2021|
|5 - Difficult Conversations||5/5/2021|
|6 - Harm Reduction and Overdose Prevention||5/12/2021|
|7 - Medications for Alcohol Use Disorder||5/19/2021|
|8 - Methamphetamine Use Disorder||5/26/2021|
|9 - Peer Perspectives on Hospital Care||6/2/2021|
|10 - Community SUD Treatment Settings||6/9/2021|
|11 - Acute pain in the Setting of Opioid Use Disorder||6/16/2021|
|12 - Organizational Buy-in for System Level Change||6/23/2021|
|13 - Participant Debrief||6/30/2021|